Nicholas J Ashton
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
Ashton, Nicholas J; Hye, Abdul; Rajkumar, Anto P; Leuzy, Antoine; Snowden, Stuart; Su�rez-Calvet, Marc; Karikari, Thomas K; Sch�ll, Michael; Joie, Renaud La; Rabinovici, Gil D; H�glund, Kina; Ballard, Clive; Hortob�gyi, Tibor; Blennow, Kaj; Svenningsson, Per; Zetterberg, Henrik; Aarsland, Dag
Authors
Abdul Hye
Dr ANTO RAJAMANI ANTO.RAJAMANI@NOTTINGHAM.AC.UK
CLINICAL ASSOCIATE PROFESSOR
Antoine Leuzy
Stuart Snowden
Marc Su�rez-Calvet
Thomas K Karikari
Michael Sch�ll
Renaud La Joie
Gil D Rabinovici
Kina H�glund
Clive Ballard
Tibor Hortob�gyi
Kaj Blennow
Per Svenningsson
Henrik Zetterberg
Dag Aarsland
Abstract
Cerebrospinal fluid analyses and neuroimaging can identify the underlying pathophysiology at the earliest stage of some neurodegenerative disorders, but do not have the scalability needed for population screening. Therefore, a blood-based marker for such pathophysiology would have greater utility in a primary care setting and in eligibility screening for clinical trials. Rapid advances in ultra-sensitive assays have enabled the levels of pathological proteins to be measured in blood samples, but research has been predominantly focused on Alzheimer disease (AD). Nonetheless, proteins that were identified as potential blood-based biomarkers for AD, for example, amyloid-β, tau, phosphorylated tau and neurofilament light chain, are likely to be relevant to other neurodegenerative disorders that involve similar pathological processes and could also be useful for the differential diagnosis of clinical symptoms. This Review outlines the neuropathological, clinical, molecular imaging and cerebrospinal fluid features of the most common neurodegenerative disorders outside the AD continuum and gives an overview of the current status of blood-based biomarkers for these disorders.
Citation
Ashton, N. J., Hye, A., Rajkumar, A. P., Leuzy, A., Snowden, S., Suárez-Calvet, M., Karikari, T. K., Schöll, M., Joie, R. L., Rabinovici, G. D., Höglund, K., Ballard, C., Hortobágyi, T., Blennow, K., Svenningsson, P., Zetterberg, H., & Aarsland, D. (2020). An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders. Nature Reviews Neurology, 16, 265-284. https://doi.org/10.1038/s41582-020-0348-0
Journal Article Type | Article |
---|---|
Acceptance Date | Nov 7, 2019 |
Online Publication Date | Apr 22, 2020 |
Publication Date | 2020-05 |
Deposit Date | Nov 12, 2019 |
Publicly Available Date | Oct 23, 2020 |
Journal | Nature Reviews Neurology |
Print ISSN | 1759-4758 |
Electronic ISSN | 1759-4766 |
Publisher | Nature Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 16 |
Pages | 265-284 |
DOI | https://doi.org/10.1038/s41582-020-0348-0 |
Public URL | https://nottingham-repository.worktribe.com/output/3233277 |
Publisher URL | https://www.nature.com/articles/s41582-020-0348-0 |
Additional Information | Accepted: 17 March 2020; First Online: 22 April 2020; : D.A. has received research support and/or honoraria from Astra-Zeneca, GE Health, H. Lundbeck and Novartis Pharmaceuticals, and served as paid consultant for Eisai, H. Lundbeck, Heptares, Mentis Cura and Sanofi. K.B. has served as a consultant or at advisory boards for Alector, Alzheon, Biogen, CogRx, Lilly, Novartis and Roche Diagnostics, all unrelated to the work presented in this paper. H.Z. has participated in scientific advisory boards for CogRx, Roche Diagnostics, Samumed and Wave, has given lectures in symposia sponsored by Alzecure and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg. M.S. has served on an advisory board for Servier. All other authors declare no competing interests. |
Contract Date | Nov 12, 2019 |
Files
NRNEUROL-18-310V1B Manuscript
(957 Kb)
PDF
You might also like
Systematic review of pharmacological interventions for people with Lewy body dementia
(2022)
Journal Article
Perspectives of GCSE students attending a psychiatry summer school in south London
(2020)
Journal Article
Systematic review of gene expression studies in people with Lewy body dementia
(2020)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search